QA: Biospecifics Technologies CORP in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875622_2012_Biospecifics_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000875622, Biospecifics Technologies CORP

  xvar xval
0 AssetsCurrent 13,086,503
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 3,178,570
4 LiabilitiesCurrent 1,116,239
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,231,881
9 ResearchAndDevelopmentExpense 972,078
10 remainder_Expenses -1,338,256
11 remainder_Revenues 11,395,726
12 remainder_NetIncome 71,603
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,265,073
1 Liabilities 1,116,239
2 Expenses 4,865,703
3 Revenues 11,395,726
4 StockholdersEquity 15,148,834
5 NetIncome 6,601,626
6 ComprehensiveNetIncome 6,601,626
7 BaseVar 16,857,172
8 EconomicCapitalRatiobeforeLimitedLiability 4.56
9 EconomicCapitalRatio 4.83

Edgar->Model Mapping

Feature Distribution